MURRAY HILL, N.J.--(BUSINESS WIRE)--June 1, 2004--Nearly five
million Americans suffer from hernias, yet only 700 thousand seek
treatment each year, according to the National Center for Health
Statistics. Many physicians believe hundreds of thousands of people
avoid hernia treatment because they fear the pain and long recovery
period once associated with hernia repair. But today's hernia repair
is not your father's hernia operation, according to Davol, Inc., a C.
R. Bard, Inc., subsidiary (BCR:NYSE).
The majority of hernias occur in the groin area where a piece of
the intestine protrudes through a weakened or torn abdominal wall.
Patients may notice a bulge in the groin or abdominal area that won't
go away with exercise or weight loss, and can become serious if left
untreated. Hernias can be repaired only through surgery. Yet new
advances in technology and techniques enable physicians to treat
hernia patients quickly, on an outpatient basis, with minimal pain and
a short recuperation period. Some techniques only necessitate use of
local anesthesia and a small incision, so patients can resume normal
activities in just days.
Hernia repair procedures using a tension-free technique help
eliminate the strain on surrounding muscles and ligaments, reducing
postoperative pain as compared to traditional tissue-to-tissue
techniques. Tension-free repair procedures using the Bard(R) Kugel(R)
Patch, Bard(R) PerFix(R) Plug, and Bard(R) Modified Kugel(R) Patch
last about 25 minutes, and patients usually walk out of the treatment
facility within one to two hours. Because this technique reduces the
pain associated with recovery, the vast majority of patients resume
normal, everyday activities quickly, often within a day or two of
surgery.
For National Hernia Awareness Month this June, Davol encourages
people who suspect they have a hernia to see their doctor and log onto
www.herniainfo.com or call 1-800-HERNIAS. Davol's mesh has been shown
to create an outstanding surgical repair with less than a one percent
chance of recurring. The Bard Mesh hernia product line has been called
"one of the most significant advances in groin hernia repairs in the
past twenty years," and continues to be the gold standard by which all
others are compared.
C. R. Bard (www.crbard.com), headquartered in Murray Hill, New
Jersey, is a leading multinational developer, manufacturer, and
marketer of innovative, life-enhancing medical technologies in the
fields of vascular, urology, oncology, and surgical specialty
products.
Davol, Inc., a C.R. Bard subsidiary, will train more than 3000
surgeons this year alone on various hernia repair techniques.
Editors, please note: The www.herniainfo.com website also provides
consumers an opportunity to receive answers to their questions by a
hernia repair surgeon.
CONTACT: For C. R. Bard, Inc.
Media Relations:
Holly P. Glass, 703-754-2848
or
Investor Relations:
Eric J. Shick, 908-277-8413
|